Form 4 filed by Venker Eric
Venker Eric filed this Form 4 on Roivant Sciences Ltd. with 3 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-02 21:37:41 UTC.
- Accession
- 0001635088-26-000108
- Filer
- CIK 1801917
- Filed
- 2026-10-02
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: Roivant Sciences Ltd. (CIK 1635088)
- Venker Eric officer (President & Immunovant CEO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Shares | 2026-09-30 | M exercised | +200,000 | $3.85 | 1,799,154 | D |
| Common Shares | 2026-09-30 | S sold | -200,000 | $36.62 | 1,599,154 | D |
| Stock Option (Right to Buy) derivative | 2026-09-30 | M exercised | -200,000 | $0 | 3,644,834 | D |